Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications

脊髓损伤中内质网应激介导的细胞死亡:从分子机制到治疗应用

阅读:2

Abstract

Spinal cord injury (SCI) is a disabling central nervous system injury that can lead to permanent loss of motor and sensory function below the level of injury. Currently, symptoms are primarily alleviated and endogenous repair mechanisms are enhanced through surgical decompression, spinal fixation, hyperbaric oxygen therapy, and drug therapy, but these methods do not directly promote nerve regeneration and functional recovery. The endoplasmic reticulum is an important organelle that plays a crucial role in maintaining cellular homeostasis. Cell death is a significant pathological event in SCI, which further worsens the microenvironment at the injury site, leading to neurological dysfunction and affecting the clinical outcomes of patients. Adverse external stimuli can induce endoplasmic reticulum stress (ERS) in the body. ERS affects cellular homeostasis and fate by activating the unfolded protein response (UPR) and mainly participates in the pathological process of SCI through regulating autophagy, apoptosis, ferroptosis, necroptosis, and other cell death programs. Current evidence suggests that cell death induced by ERS may be an important pathological mechanism determining the prognosis and outcome of SCI. This article systematically reviews the research progress on ERS and UPR in the regulation of cell death in SCI. We focus on integrating the evidence and possible mechanisms linking ERS with four typical modes of cell death. Furthermore, we summarize advances in understanding the involvement of ERS/UPR in processes including inflammation amplification, mitochondrial dysfunction, oxidative stress, and nerve repair in SCI. On this basis, this article summarizes potential intervention targets and therapeutic strategies, aiming to provide a clearer integrative framework for understanding the pathological mechanisms of SCI and to offer reference directions for subsequent basic research and clinical translational studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。